e delivery system, significantly improves the Pharmacokinetics of drugs with either narrow absorption window or poorly soluble drugs that belong to Biopharmaceutics Classification System (BCS) class II and Class IV. (personalized diagnostics maybe Alzheimers) Rosetta Genomics discovers, develops and commercializes next generation d